Metabolic syndrome and comorbidities in patients with psoriasis: a community-based case-control study from the Nagahama cohort in Japan

[1] Stefanadi EC(2018)Metabolic syndrome and the skin: a more than superficial association. Reviewing the association between skin diseases and metabolic syndrome and a clinical decision algorithm for high risk patients Diabetol Metab Syndr 10 9-85

[2] Dimitrakakis G(2014)A survey of the status of psoriasis conducted using information obtained from health insurance claims provided by health insurance societies Rinsho lyaku 30 279-22

[3] Antoniou CK(2015)Epidemiology of psoriasis and palmoplantar pustulosis: a nationwide study using the Japanese national claims database BMJ Open 5 e006450-9

[4] Terui T(1965)Cardiovascular, metabolic and thermoregulatory disturbances in patients with erythrodermic skin diseases Br Med J 1 619-66.e8

[5] Nakagawa H(2016)Metabolic syndrome is a strong risk factor for minor ischemic stroke and subsequent vascular events PLoS One 11 e0156243-73

[6] Eto T(2015)Is metabolic syndrome predictive of prevalence, extent, and risk of coronary artery disease beyond its components? Results from the multinational coronary CT angiography evaluation for clinical outcome: an international multicenter registry (CONFIRM) PLoS One 10 e0118998-7

[7] Ozawa A(2019)Metabolic syndrome and risk of incident psoriasis: prospective data from the HUNT Study, Norway Br J Dermatol 180 94-5

[8] Kubota K(2017)An update on psoriasis and metabolic syndrome: a meta-analysis of observational studies PLoS One 12 e0181039-7

[9] Kamijima Y(2017)Systematic review and meta-analysis of the association between psoriasis and metabolic syndrome J Am Acad Dermatol 77 657-401

[10] Sato T(2007)Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study Br J Dermatol 157 68-85

[1] Stefanadi EC(2018)Metabolic syndrome and the skin: a more than superficial association. Reviewing the association between skin diseases and metabolic syndrome and a clinical decision algorithm for high risk patients Diabetol Metab Syndr 10 9-85

[2] Dimitrakakis G(2014)A survey of the status of psoriasis conducted using information obtained from health insurance claims provided by health insurance societies Rinsho lyaku 30 279-22

[3] Antoniou CK(2015)Epidemiology of psoriasis and palmoplantar pustulosis: a nationwide study using the Japanese national claims database BMJ Open 5 e006450-9

[4] Terui T(1965)Cardiovascular, metabolic and thermoregulatory disturbances in patients with erythrodermic skin diseases Br Med J 1 619-66.e8

[5] Nakagawa H(2016)Metabolic syndrome is a strong risk factor for minor ischemic stroke and subsequent vascular events PLoS One 11 e0156243-73

[6] Eto T(2015)Is metabolic syndrome predictive of prevalence, extent, and risk of coronary artery disease beyond its components? Results from the multinational coronary CT angiography evaluation for clinical outcome: an international multicenter registry (CONFIRM) PLoS One 10 e0118998-7

[7] Ozawa A(2019)Metabolic syndrome and risk of incident psoriasis: prospective data from the HUNT Study, Norway Br J Dermatol 180 94-5

[8] Kubota K(2017)An update on psoriasis and metabolic syndrome: a meta-analysis of observational studies PLoS One 12 e0181039-7

[9] Kamijima Y(2017)Systematic review and meta-analysis of the association between psoriasis and metabolic syndrome J Am Acad Dermatol 77 657-401

[10] Sato T(2007)Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study Br J Dermatol 157 68-85